602 A phase I trial of atezolizumab and varlilumab in combination with radiation in patients with metastatic non-small cell lung cancer (NSCLC)

• Yong Lin,
• Jyoti Malhotra,
• Salma K Jabbour,
• Michael J Yellin,
• Malini Patel,
• Emmanuel Zachariah,
• Curtis Krier,
• Ankit Saxena

Affiliations

Yong Lin

4 Sanofi Genzyme, Bridgewater, New Jersey, USA

Jyoti Malhotra

Aff293 grid.430387.b0000000419368796Rutgers Cancer Institute of New Jersey New Brunswick NJ USA

Salma K Jabbour

Radiation Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA

Michael J Yellin

4Celldex Therapeutics, Inc., Hampton, NJ, USA

Malini Patel

6Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA

Emmanuel Zachariah

2Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA

Curtis Krier

2Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA

Ankit Saxena

2Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA